Dupixent (dupilumab)

pCPA File Number: 22214
Negotiation Status:
Under consideration for negotiation
Indication(s):
atopic dermatitis
Sponsor/Manufacturer:
Sanofi Genzyme Canada
CADTH Project Number:
SF0754
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable